The Scientific Advisory Board (SAB) is comprised of experts in oncology, immunology, protein engineering, drug discovery and development. The SAB provides strategic and scientific counsel to Ichnos’ management and research and development team to help advance the company’s proprietary BEAT® platform and multispecifics directed at blood cancers and solid tumors.
Associate Professor of Medicine, Director, Myeloma Immunotherapy, at the University of Pennsylvania, USA
Professor of Medicine, Deputy Division Head of Hematologic Malignancies at Memorial Sloan Kettering Cancer Center, USA
Professor of Clinical Hematology, Head of Translational Research at the University Hospital of Nantes, France
Biotechnology Professor and Department Director at the Technische Universität Braunschweig, Germany
Professor of Medicine, Head of Translational Cancer Immunology at Ludwig-Maximillans-Universitat, Germany
Entrepreneur in Residence at Third Rock Ventures, Cambridge, Mass, USA
Director, Ichnos Sciences, Adjunct Assistant Professor and Special Advisor to the President for Corporate Relations at the Medical University of South Carolina, USA
The link above is provided for your convenience, and Ichnos is not responsible for content, privacy, or security issues associated with your visit to external websites.